Cargando…
Number of drugs provided by the Pharmaceutical Benefits Scheme and mortality and hospital utilization in Australia, 2002–2019
We analyze the relationship between long-run changes in the drugs provided by the Pharmaceutical Benefits Scheme (PBS) and mortality and hospital utilization in Australia, by analyzing the correlation across diseases between the change in the number of drugs used to treat the disease provided and th...
Autor principal: | Lichtenberg, Frank R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507438/ https://www.ncbi.nlm.nih.gov/pubmed/37731531 http://dx.doi.org/10.1016/j.ssmph.2023.101514 |
Ejemplares similares
-
Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme
por: Duckett, Stephen J.
Publicado: (2004) -
The Pharmaceutical Benefits Scheme 2003–2004
por: Harvey, Ken J
Publicado: (2005) -
Trends of suicide rates by gender and residence in China from 2002 to 2019
por: Hu, Yuhua, et al.
Publicado: (2023) -
HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme
por: Dharan, Nila J., et al.
Publicado: (2019) -
PB2082: POPULATION-WIDE PATTERNS OF CARE IN MANTLE CELL LYMPHOMA IN AUSTRALIA: AN ANALYSIS OF THE PHARMACEUTICAL BENEFITS SCHEME DATASET
por: Tam, C., et al.
Publicado: (2022)